3930-83-4 | 2-Iodobenzamide

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$5.00	$4.00
5g	98%	in stock	$10.00	$7.00
10g	98%	in stock	$18.00	$13.00
25g	98%	in stock	$25.00	$18.00
100g	98%	in stock	$95.00	$67.00

Description

• Catalog Number: AF68531
• Chemical Name: 2-Iodobenzamide
• CAS Number: 3930-83-4
• Molecular Formula: C7H6INO
• Molecular Weight: 247.0331
• MDL Number: MFCD00099248
• SMILES: NC(=O)c1ccccc1I
• NSC Number: 136970

Computed Properties

• Complexity: 138
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 10
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 1
• XLogP3: 0.9

Literature

• SPECT molecular imaging in Parkinson's disease.

  Journal of biomedicine & biotechnology 20120101

• Synthesis of cytimidine through a one-pot copper-mediated amidation cascade.

  Organic letters 20111007

• Imaging of the pituitary: Recent advances.

  Indian journal of endocrinology and metabolism 20110901

• Molecular SPECT Imaging: An Overview.

  International journal of molecular imaging 20110101

• Preliminary studies of differential impairments of the dopaminergic system in subtypes of progressive supranuclear palsy.

  Nuclear medicine communications 20101101

• Cortical and subcortical patterns of I-123 iodobenzamide SPECT in striatal D(2) receptor parkinsonisms.

  Clinical nuclear medicine 20100401

• Preparation and biological evaluation of cyclopentadienyl-based 99mTc-complexes [(Cp-R)99mTc(CO)3] mimicking benzamides for malignant melanoma targeting.

  Nuclear medicine and biology 20100401

• Targeting murine heart and brain: visualisation conditions for multi-pinhole SPECT with (99m)Tc- and (123)I-labelled probes.

  European journal of nuclear medicine and molecular imaging 20090901

• Pharmacology and therapeutic potential of sigma(1) receptor ligands.

  Current neuropharmacology 20081201

• Striatal D(2) receptor occupancy in bipolar patients treated with olanzapine.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070115

• Novel alpha,alpha-difluorohomophthalimides via copper-catalyzed tandom cross-coupling-cyclization of 2-halobenzamides with alpha,alpha-difluoro Reformatskii reagent.

  The Journal of organic chemistry 20050610

• High resolution magic angle spinning NMR spectroscopy used to investigate the ability of drugs to bind to synthetic melanin.

  Pigment cell research 20050201

• Ultra-structural cell distribution of the melanoma marker iodobenzamide: improved potentiality of SIMS imaging in life sciences.

  Biomedical engineering online 20040101

• Synthesis and affinity of a possible byproduct of electrophilic radiolabeling of [123I]IBZM.

  Bioorganic & medicinal chemistry letters 20031117

• Synthesis and structure of amino acid-derived benziodazoles: new hypervalent iodine heterocycles.

  Organic letters 20030501

• Sigma receptor scintigraphy with N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide of patients with suspected primary breast cancer: first clinical results.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20021201

• Is increased D2 receptor availability associated with response to stimulant medication in ADHD.

  Developmental medicine and child neurology 20011101